生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Fisogatinib, also known as BLU-554, is a strong, highly selective, and orally bioavailable inhibitor of FGFR4, exhibiting IC50 value of 5 nM. It demonstrates considerable efficacy against tumors in hepatocellular carcinoma (HCC) models that rely on FGFR4 signaling[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.99mL 0.40mL 0.20mL |
9.93mL 1.99mL 0.99mL |
19.87mL 3.97mL 1.99mL |
参考文献 |
---|